Companies · Other Health Care

SCA-Denver Physicians Holdings, LLC

BIRMINGHAM · Other Health Care

Diligence memoA one-page analyst read on SCA-Denver Physicians Holdings, LLC — recommendation, valuation, rhythm, risks.
$4.7M
Total raised · real
8
Rounds
0.1×
Latest step-up
Top 38%
Sector rank · raised
Seed
Latest stage · inferred · Fri Oct 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

SCA-Denver Physicians Holdings, LLC looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.11× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Active
  • Last raise 9 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

SCA-Denver Physicians Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
6.4 yr record
Peak capital year was 2025 with $6.7M across 3 filings.
Market position
ahead of 63% of Other Health Care peers
Capital scale is ahead of 63% of Other Health Care peers; modeled value is above 3% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2025: $6.7M across 3 filings.
  • Largest single filing was $3.3M on 2025-01-31.
  • Filing rows sum to $8.0M, while canonical raised total is $4.7M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

SCA-Denver Physicians Holdings, LLC is one of 5377 Other Health Care companies tracked from BIRMINGHAM. By capital raised it ranks mid-pack (ahead of 63% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2025
Year incorporated
2025-10-03
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2020-01-29 Raised $143K (real) Modeled valuation $4.4M (est)Pre-Seed2020Pre-Seed · 2021-02-08 Raised $150K (real) Modeled valuation $3.4M (est)Pre-Seed2021Pre-Seed · 2021-08-11 Raised $141K (real) Modeled valuation $2.5M (est)Pre-Seed2021Pre-Seed · 2022-01-05 Raised $243K (real) Modeled valuation $3.5M (est)Pre-Seed2022Pre-Seed · 2023-02-24 Raised $203K (real) Modeled valuation $1.7M (est)Pre-Seed2023Pre-Seed · 2024-04-02 Raised $361K (real) Modeled valuation $1.7M (est)Pre-Seed2024Seed · 2025-01-29 Raised $3.3M (real) Modeled valuation $11M (est)Seed2025Seed · 2025-01-31 Raised $3.3M (real) Modeled valuation $11M (est)Seed2025Seed · 2025-10-03 Raised $187K (real) Modeled valuation $484K (est)Seed2025+$150K+$141K+$243K+$203K+$361K+$3.3M+$3.3M+$187KCumulative $8.0M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$143K · 2020
Pre-Seed extension$150K · 2021
Pre-Seed extension$141K · 2021
Pre-Seed extension$243K · 2022
Pre-Seed extension$203K · 2023
Pre-Seed extension$361K · 2024
Seed$3.3M · 2025
Seed extension$3.3M · 2025
Seed extension$187K · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$484K
Base estimate est.
$158K
Conservative case
$918K
Upside case
$935K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $4.4M · 2020-01-292020Pre-Seed · modeled $3.4M · 2021-02-08Pre-Seed · modeled $2.5M · 2021-08-11Pre-Seed · modeled $3.5M · 2022-01-05Pre-Seed · modeled $1.7M · 2023-02-24Pre-Seed · modeled $1.7M · 2024-04-02Seed · modeled $11.3M · 2025-01-29Seed · modeled $11.3M · 2025-01-31Seed · modeled $484K · 2025-10-032025
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
0.7 yr
Elapsed time used
0.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$828K/yr
Capital velocity
6.4 yr
On record since
2020
First round
9
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.9× above median
This company$4.7M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.1× of median
This company$187K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$484K
Sector median$22.1M

Raised more than 63% of sector peers (real $). Modeled value above 3% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #99 of 105.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Xymogen, Inc. · Seed Raised $62.4M · modeled $12.3M (est)Willow Life Sciences, Inc. · Seed Raised $4.0M · modeled $12.0M (est)ManyClicks, Inc. · Seed Raised $4.0M · modeled $11.7M (est)Sterile State, Inc. · Seed Raised $3.2M · modeled $11.5M (est)Limber Prosthetics, Inc. · Seed Raised $3.8M · modeled $11.1M (est)Othership Inc. · Seed Raised $3.7M · modeled $11.1M (est)Ps-Fertility, Inc. · Seed Raised $3.5M · modeled $11.0M (est)Eagle Onsite, Llc · Seed Raised $3.5M · modeled $10.6M (est)ForCast Orthopedics, Inc. · Seed Raised $3.8M · modeled $10.6M (est)1888 Equity LLC · Seed Raised $3.0M · modeled $10.5M (est)Arrellio, Inc. · Seed Raised $3.5M · modeled $10.0M (est)Kindbridge Corp · Seed Raised $5.4M · modeled $9.9M (est)SCA-Denver Physicians Holdings, LLC (this company) Raised $4.7M · modeled $484K (est)SCA-Denver Physicians Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Xymogen, Inc.Seed$62.4M$12.3M2.89×
Willow Life Sciences, Inc.Seed$4.0M$12.0M2.84×
ManyClicks, Inc.Seed$4.0M$11.7M2.75×
Sterile State, Inc.Seed$3.2M$11.5M2.70×
Limber Prosthetics, Inc.Seed$3.8M$11.1M2.63×
Othership Inc.Seed$3.7M$11.1M2.61×
Ps-Fertility, Inc.Seed$3.5M$11.0M2.59×
Eagle Onsite, LlcSeed$3.5M$10.6M2.51×
ForCast Orthopedics, Inc.Seed$3.8M$10.6M2.50×
1888 Equity LLCSeed$3.0M$10.5M2.48×
Arrellio, Inc.Seed$3.5M$10.0M2.35×
Kindbridge CorpSeed$5.4M$9.9M2.33×
SCA-Denver Physicians Holdings, LLC this companySeed$4.7M$484K0.11×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$143K2020-01-29$795K$4.4M90%
Pre-Seed$150K2021-02-08$835K$3.4M90%
Pre-Seed$141K2021-08-11$784K$2.5M90%
Pre-Seed$243K2022-01-05$1.4M$3.5M90%
Pre-Seed$203K2023-02-24$1.1M$1.7M90%
Pre-Seed$361K2024-04-02$2.0M$1.7M90%
Seed$3.3M2025-01-29$16.3M$11.3M90%
Seed$3.3M2025-01-31$16.4M$11.3M90%
Seed$187K2025-10-03$935K$484K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$143K2020-01-29
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$150K2021-02-08
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  3. Pre-Seed$141K2021-08-11
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  4. Pre-Seed$243K2022-01-05
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
  5. Pre-Seed$203K2023-02-24
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  6. Pre-Seed$361K2024-04-02
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
  7. Seed$3.3M2025-01-29
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 9.0× larger than the prior — scaling up.
  8. Seed$3.3M2025-01-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  9. Seed$187K2025-10-03
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 17.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~9mo cadence
$187K
Modeled next size est.range $187K$299K
0.1×
Last step-up
$828K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brian Shelton7 other2020-01
Bill Linder3 other2020-01
Chris Elliott2 other2021-02
Geoffrey Burgess2 other2023-02
Jason Richardson2 other2024-04
Cody Carlin1 other2025-10
Craig Davis1 other2024-04
Ezra Erb1 other2020-01
Peter Burd1 other2021-02
Brian Larkin, M.D.2024-04
Brian Larkin, MD2020-01
Cary Motz, M.D.2024-04
Cary Motz, MD2020-01
Craig Davis, MD2021-08
Molly Dolzani2025-10
Opi Okuffo2020-01
Phil Stull, MD2020-01
Sarah Gregory2021-02
Registry & provenance

SCA-Denver Physicians Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1804134
SEC CIK
2025
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Surgery Center of Highlands Ranch, LLCOther Health CareSeed$2.3M$13.0Mnetwork3 shared operators · same sector · same stage
Dry Creek Surgery Center /CO/ LLCOther Health CarePre-Seed$264K$197Knetwork4 shared operators · same sector
Surgery Center at Kissing Camels, LLCOther Health CarePre-Seed$366K$8.6Mnetwork2 shared operators · same sector
SJ East Campus ASC, LLCOther Health CareSeed$1.1M$21.2Mnetwork1 shared operator · same sector · same stage
Mile High Surgicenter, LLCOther Health CarePre-Seed$181K$5.6Mnetwork2 shared operators · same sector
Joliet Surgery Center Limited PartnershipOther Health CareSeed$4.7M$728Ksame sector · same stage
Pelvital Usa, Inc.Other Health CareSeed$4.7M$435Ksame sector · same stage
OS1 Holdings, Inc.Other Health CareSeed$4.8M$1.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
SCA-Bethesda, LLCOther Health CarePre-Seed$481K90%
SCA-Castle Rock, LLCOther Health CarePre-Seed$3.0M87%
SCA-Sand Lake, LLCOther Health CarePre-Seed$2.7M87%
SCA-Doral, LLCOther Health CarePre-Seed$1.0M86%
SCA-Grove Place, LLCOther Health CarePre-Seed$1.9M86%
SCA-Central Florida, LLCOther Health CarePre-Seed$4.9M86%
SCA-Bonita Springs, LLCOther Health CarePre-Seed$1.8M85%
SCA-Gladiolus, LLCOther Health CarePre-Seed$501K84%
Frequently asked
How much funding has SCA-Denver Physicians Holdings, LLC raised?
SCA-Denver Physicians Holdings, LLC has raised approximately $4.7M in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is SCA-Denver Physicians Holdings, LLC's estimated valuation?
Provath's modeled valuation for SCA-Denver Physicians Holdings, LLC is approximately $484K (modeled range $158K–$918K). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is SCA-Denver Physicians Holdings, LLC at?
SCA-Denver Physicians Holdings, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Oct 03.
What does SCA-Denver Physicians Holdings, LLC do and where is it based?
SCA-Denver Physicians Holdings, LLC operates in the Other Health Care sector, based in BIRMINGHAM.
Explore related

See where SCA-Denver Physicians Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at SCA-Denver Physicians Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.